Cefdinir and Emla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefdinir (cefdinir) and Emla (lidocaine; prilocaine). Common drug interactions include alopecia among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Emla. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

17 people who take Cefdinir and Emla together, and have interactions are studied.

What are the common drug interactions of Cefdinir and Emla, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Aspartate aminotransferase increased
Cardiac murmur (an heart sound in valve abnormality)
Constipation
Failure to thrive (inadequate weight gain and physical growth in children)
Fall
Herpes zoster
Hypotension (abnormally low blood pressure)
Ileus (a painful obstruction of the ileum or other part of the intestine)
Influenza like illness

male:

Nausea (feeling of having an urge to vomit)
Beta haemolytic streptococcal infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue)
Death
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Pyrexia (fever)
Terminal state (the transitional states between life and biological death)
Waist circumference increased

What are the common drug interactions of Cefdinir and Emla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)

10-19:

n/a

20-29:

Beta haemolytic streptococcal infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Infusion related reaction
Pyrexia (fever)
Rash erythematous (redness of the skin)
Waist circumference increased

30-39:

n/a

40-49:

n/a

50-59:

Cardiac murmur (an heart sound in valve abnormality)
Constipation
Fatigue (feeling of tiredness)
Herpes zoster
Ileus (a painful obstruction of the ileum or other part of the intestine)
Influenza like illness
Muscular weakness (muscle weakness)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Nasopharyngitis (inflammation of the nasopharynx)
Pericardial effusion (fluid around the heart)

60+:

Failure to thrive (inadequate weight gain and physical growth in children)
Fall
Pruritus (severe itching of the skin)
Pyrexia (fever)
Bone marrow disorder
Death
Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

Pain: 8 people, 47.06%
Nausea (feeling of having an urge to vomit): 5 people, 29.41%
Constipation: 4 people, 23.53%
Metastases To Central Nervous System (cancer spreads to central nervous system): 4 people, 23.53%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 17.65%
Malignant Melanoma (skin cancer rises from melancytes): 3 people, 17.65%
Stress And Anxiety: 2 people, 11.76%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.76%
Blood Magnesium Decreased: 2 people, 11.76%
Brain Neoplasm Malignant (brain cancer tumour): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Emla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously